Actively Recruiting
Role of NADPH Oxidase in Microvascular Dysfunction Following GDM
Led by Anna Stanhewicz, PhD · Updated on 2025-05-13
40
Participants Needed
1
Research Sites
248 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this investigation is to examine NADPH oxidase as a source of reactive oxygen species contributing to aberrant microvascular function in otherwise healthy women with a history of GDM.
CONDITIONS
Official Title
Role of NADPH Oxidase in Microvascular Dysfunction Following GDM
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years or older
- Pregnant within 5 years of the study visit
- Diagnosed with gestational diabetes by an obstetrician and confirmed by American College of Obstetricians and Gynecologists criteria
- Or without a history of gestational diabetes
You will not qualify if you...
- Skin diseases
- Current use of tobacco or electronic cigarette/vape pen
- Diagnosed or suspected liver or metabolic diseases including diabetes
- Use of statins or other cholesterol-lowering medications
- Current use of antihypertensive medications
- History of preeclampsia or gestational hypertension
- Currently pregnant
- Body mass index less than 18.5 kg/m2
- Allergy to materials used during the experiment (e.g., latex)
- Known allergies to study drugs
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Iowa
Iowa City, Iowa, United States, 52242
Actively Recruiting
Research Team
A
Anna Reid-Stanhewicz, PHD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
BASIC_SCIENCE
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here